Svjetlana Mohrmann Selected Research

Svjetlana Mohrmann Research Topics

25	Breast Neoplasms (Breast Cancer) 02/2022 - 12/2005
12	Neoplasms (Cancer) 02/2022 - 01/2007
3	Neoplasm Metastasis (Metastasis) 11/2021 - 08/2006
1	Residual Neoplasm 02/2022
1	Body Weight (Weight, Body) 01/2018
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2018
1	Aneuploidy (Aneuploid) 04/2015
1	Circulating Neoplastic Cells 10/2013
1	Mastitis 06/2012
1	Diabetes Mellitus 06/2012
1	Carcinoma (Carcinomatosis) 10/2008

6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 11/2020
3	Epirubicin (Ellence)FDA LinkGeneric 01/2018 - 10/2008
3	Hormones (Hormone)IBA 03/2017 - 12/2009
3	Proteins (Proteins, Gene)FDA Link 04/2011 - 01/2007
2	human ERBB2 proteinIBA 01/2021 - 12/2009
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 11/2014
2	Estrogen ReceptorsIBA 01/2021 - 11/2014
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 08/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 08/2016
2	AnthracyclinesIBA 04/2015 - 08/2012
2	taxaneIBA 04/2015 - 08/2012
2	SteroidsIBA 06/2012 - 12/2009
1	Capecitabine (Xeloda)FDA Link 02/2022
1	Chromogranin AIBA 01/2022
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2022
1	SynaptophysinIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 11/2019
1	Docetaxel (Taxotere)FDA Link 01/2018
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 08/2016
1	DNA (Deoxyribonucleic Acid)IBA 08/2016
1	Methotrexate (Mexate)FDA LinkGeneric 08/2016
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 08/2016
1	Tissue Inhibitor of MetalloproteinasesIBA 04/2015
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 04/2015
1	Tissue Inhibitor of Metalloproteinase-1IBA 04/2015
1	Biomarkers (Surrogate Marker)IBA 10/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2012
1	Y-Box-Binding Protein 1IBA 12/2009
1	karyopherin alpha 2IBA 09/2008
1	ParaffinIBA 01/2007
1	Phenobarbital (Luminal)FDA Link 01/2007

12	Drug Therapy (Chemotherapy) 02/2022 - 12/2005
8	Therapeutics 02/2022 - 12/2009
4	Radiotherapy 04/2020 - 03/2017
4	Adjuvant Chemotherapy 01/2018 - 12/2009
2	Segmental Mastectomy (Lumpectomy) 04/2020 - 03/2017
2	Chemoradiotherapy 04/2020 - 07/2019
2	Mastectomy (Mammectomy) 04/2020 - 01/2018
1	Immunotherapy 02/2022
1	Neoadjuvant Therapy 02/2022
1	Adjuvant Radiotherapy 03/2017
1	Induction Chemotherapy 08/2006
1	Stem Cell Transplantation 08/2006